Patent · US Active

Prevention, diagnosis and treatment of cancer overexpressing GPR160

US10865415B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES · CN

Inventors

Caihong Zhou · Shanghai, CN
Xinchuan DAI · Shanghai, CN
Mingwei Wang · Longbeilingcun, CN

Key dates

Filing date	Sep 29, 2016
Grant date	Dec 15, 2020
Priority date	—
Expiry date	Oct 10, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a dsRNA construct of an orphan G-protein-coupled receptor GPR160 gene related to prostate cancer and the use thereof, wherein the dsRNA construct of the GPR160 gene and a composition thereof can prevent or treat prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.